These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19062597)

  • 21. Hyperosmolar blood-brain barrier disruption in baboons: an in vivo study using positron emission tomography and rubidium-82.
    Zünkeler B; Carson RE; Olson J; Blasberg RG; Girton M; Bacher J; Herscovitch P; Oldfield EH
    J Neurosurg; 1996 Mar; 84(3):494-502. PubMed ID: 8609564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted delivery in primary and metastatic brain tumors: summary report of the seventh annual meeting of the Blood-Brain Barrier Disruption Consortium.
    Doolittle ND; Abrey LE; Ferrari N; Hall WA; Laws ER; McLendon RE; Muldoon LL; Peereboom D; Peterson DR; Reynolds CP; Senter P; Neuwelt EA
    Clin Cancer Res; 2002 Jun; 8(6):1702-9. PubMed ID: 12060607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm.
    Gerstner ER; Fine RL
    J Clin Oncol; 2007 Jun; 25(16):2306-12. PubMed ID: 17538177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mannitol opens pathway of brain tumor chemotherapy.
    Gunby P
    JAMA; 1981 May; 245(18):1802. PubMed ID: 6785456
    [No Abstract]   [Full Text] [Related]  

  • 25. Understanding brain penetrance of anticancer drugs.
    Levin VA; Ellingson BM
    Neuro Oncol; 2018 Apr; 20(5):589-596. PubMed ID: 29474640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New methods of drug delivery through the blood brain barrier].
    Bruhn C
    Dtsch Med Wochenschr; 2012 May; 137(21):p18. PubMed ID: 22622506
    [No Abstract]   [Full Text] [Related]  

  • 27. Improving the transport of chemotherapeutic drugs across the blood-brain barrier.
    Orthmann A; Fichtner I; Zeisig R
    Expert Rev Clin Pharmacol; 2011 Jul; 4(4):477-90. PubMed ID: 22114857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-time monitoring of human blood-brain barrier disruption.
    Kiviniemi V; Korhonen V; Kortelainen J; Rytky S; Keinänen T; Tuovinen T; Isokangas M; Sonkajärvi E; Siniluoto T; Nikkinen J; Alahuhta S; Tervonen O; Turpeenniemi-Hujanen T; Myllylä T; Kuittinen O; Voipio J
    PLoS One; 2017; 12(3):e0174072. PubMed ID: 28319185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging and drug delivery to tumor-infiltrated brain.
    Black KL
    Clin Neurosurg; 1994; 41():563-72. PubMed ID: 7842624
    [No Abstract]   [Full Text] [Related]  

  • 30. [Animal experimental studies on the permeability effectiveness of modern drugs (psychotropic drugs and antigoagulants) together with a contribution on different modes of action on the blood-brain barrier].
    Liebaldt G
    Arzneimittelforschung; 1965 Sep; 15(9):1056-60. PubMed ID: 4159770
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of hyperosmotic blood-brain barrier disruption on transcapillary transport in canine brain tumors.
    Groothuis DR; Warkne PC; Molnar P; Lapin GD; Mikhael MA
    J Neurosurg; 1990 Mar; 72(3):441-9. PubMed ID: 2106016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
    Juillerat-Jeanneret L
    Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational brain tumor chemotherapy. The interaction of drug and tumor.
    Groothuis DR; Blasberg RG
    Neurol Clin; 1985 Nov; 3(4):801-16. PubMed ID: 3908896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Problems specific to chemotherapy of intracerebral tumors].
    Hirsch JF
    Neurochirurgie; 1974; 20(3):233-46. PubMed ID: 4219038
    [No Abstract]   [Full Text] [Related]  

  • 35. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic disruption of the blood brain barrier in metastasis.
    Jandial R; Neman J; Chen MY
    Neurosurgery; 2014 Apr; 74(4):N11-2. PubMed ID: 24642987
    [No Abstract]   [Full Text] [Related]  

  • 37. Overcoming the blood-brain barrier in chemotherapy treatment of pediatric brain tumors.
    Wu L; Li X; Janagam DR; Lowe TL
    Pharm Res; 2014 Mar; 31(3):531-40. PubMed ID: 23996470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Polychemotherapy of primary and secondary brain tumors].
    Heiss WD; Kübböck J; Kroiss A; Poustka F
    Wien Med Wochenschr; 1972 Sep; 122(38):530-4. PubMed ID: 4653068
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemotherapy delivery issues in central nervous system malignancy: a reality check.
    Muldoon LL; Soussain C; Jahnke K; Johanson C; Siegal T; Smith QR; Hall WA; Hynynen K; Senter PD; Peereboom DM; Neuwelt EA
    J Clin Oncol; 2007 Jun; 25(16):2295-305. PubMed ID: 17538176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re: Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
    Goldstein DA; Tessler HH
    Am J Ophthalmol; 2007 Dec; 144(6):976; author reply 976. PubMed ID: 18036877
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.